Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study. [electronic resource]
Producer: 19850826Description: 969-76 p. digitalISSN:- 0732-183X
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- BCG Vaccine -- administration & dosage
- Carcinoma, Small Cell -- mortality
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Evaluation Studies as Topic
- Female
- Humans
- Immunotherapy
- Lomustine -- administration & dosage
- Lung Neoplasms -- mortality
- Male
- Methotrexate -- administration & dosage
- Prognosis
- Radiotherapy Dosage
- Radiotherapy, High-Energy
- Random Allocation
- Sex Factors
- Time Factors
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.